<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02509000</url>
  </required_header>
  <id_info>
    <org_study_id>WHuang14</org_study_id>
    <nct_id>NCT02509000</nct_id>
  </id_info>
  <brief_title>Beijing Indoor Air Purifier Intervention Study</brief_title>
  <acronym>BIAPSY</acronym>
  <official_title>Beijing Indoor Air Purifier Intervention Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>WeiHuang</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Peking University Third Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Utrecht University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Peking University</source>
  <brief_summary>
    <textblock>
      This study aimed to assess the impact of air filtration on indoor air quality and
      cardio-pulmonary health in residents living in high outdoor pollution settings in Beijing.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Actual">November 2014</completion_date>
  <primary_completion_date type="Actual">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>respiratory inflammation</measure>
    <time_frame>4 weeks</time_frame>
    <description>analyzed EBC pH and inflammation biomarkers 8-isoprostane and nitrite and nitrate</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>systemic inflammation</measure>
    <time_frame>4 weeks</time_frame>
    <description>analyzed systemic inflammation biomarkers C-reaction Protein, Blood coagulation factor fibrinogen (Fib), Interleukin (IL) -8, -1β, -6, -10, -12p70 and tumor necrosis factor-α (TNF-α)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>oxidative stress</measure>
    <time_frame>4 weeks</time_frame>
    <description>analyzed systemic oxidative stress biomarker urinary 8-hydroxy-2-deoxyguanosine (8-OHdG)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>lung function</measure>
    <time_frame>4 weeks</time_frame>
    <description>lung function test (FEV1, FEV1 %predicted, FEV1/FVC, 176 maximum midexpiratory flow (MMEF), MMEF %predicted) using an Aspirometer</description>
  </other_outcome>
  <other_outcome>
    <measure>autonomic function</measure>
    <time_frame>4 weeks</time_frame>
    <description>twelve-hour ambulatory electrocardiogram (ECG) and blood pressure (BP) were monitored</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">35</enrollment>
  <condition>Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>Active-mode</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Air purifier in active-mode</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham-mode</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Air purifier in sham-mode</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>air purifier</intervention_name>
    <description>filtration units randomly allocated to active- and sham-mode in 20 recruited households for four weeks</description>
    <arm_group_label>Active-mode</arm_group_label>
    <arm_group_label>Sham-mode</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Global Initiative for Chronic Obstructive Lung Disease criteria (mild to moderate,
             GOLD stage I~II;

          -  severe to very severe, GOLD stage III~IV) quit smoking for at least 1 year;

          -  a ratio of pre-bronchodilator forced expiratory volume in one second (FEV1) to forced
             vital capacity (FVC) equal to or less than 0.70 and an increase of FEV1 with the use
             of 400μg of albuterol of less than 12% of the pre-bronchodilator one;

          -  no history of asthma or any other active lung disease.

          -  Subjects were free from exacerbations for at least 6 weeks.

        Exclusion Criteria:

          -  Patients with heart pacemaker,

          -  heart failure with bundle-branch block,

          -  recent myocardial infarction (in the last 12 weeks) and

          -  anticoagulant therapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wei Huang, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Peking University School of Public Health</affiliation>
  </overall_official>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 20, 2015</study_first_submitted>
  <study_first_submitted_qc>July 23, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 27, 2015</study_first_posted>
  <last_update_submitted>October 20, 2015</last_update_submitted>
  <last_update_submitted_qc>October 20, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 21, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Peking University</investigator_affiliation>
    <investigator_full_name>WeiHuang</investigator_full_name>
    <investigator_title>Peking University School of Public Health</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

